Rana Davis
Family · Gadsden, ALNPI 1720499403
Payments from drug & device makers
Across 323 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$476
- Exact Sciences$453
- Lilly USA, LLC$424
- AstraZeneca$409
- Pfizer$360
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,00198%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 102 | $1,377 |
| GSK | 27 | $476 |
| Exact Sciences | 31 | $453 |
| Lilly USA, LLC | 37 | $424 |
| AstraZeneca | 21 | $409 |
| Pfizer | 21 | $360 |
| Amgen | 15 | $258 |
| Abbott | 9 | $178 |
| Bayer | 8 | $146 |
| Novartis | 6 | $122 |
| Astellas Pharma US Inc | 3 | $121 |
| Xeris Pharmaceuticals, Inc. | 5 | $103 |
| Novo Nordisk | 7 | $100 |
| Phathom Pharmaceuticals, Inc. | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Dexcom, Inc. | 4 | $74 |
| Boehringer Ingelheim | 3 | $51 |
| Merck | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
How this compares
$5,095 in reported general payments places this provider in the 90th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 64 | $121,616 |
| OzempicSemaglutide | 41 | $70,775 |
| EliquisApixaban | 45 | $44,987 |
| XareltoRivaroxaban | 46 | $40,766 |
| MounjaroTirzepatide | 19 | $28,528 |
| JardianceEmpagliflozin | 15 | $26,594 |
| EntrestoSacubitril/Valsartan | 16 | $21,737 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $19,298 |
| FarxigaDapagliflozin Propanediol | 15 | $12,792 |
| Lagevrio (Eua)Molnupiravir | 16 | $5,773 |
| Atorvastatin Calcium | 230 | $4,078 |
| Levothyroxine Sodium | 261 | $3,943 |
| Pravastatin Sodium | 149 | $3,295 |
| Losartan Potassium | 187 | $2,825 |
| Pantoprazole Sodium | 205 | $2,785 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $424 | $150,14483 claims |
| Novo NordiskOzempic | $100 | $70,77541 claims |
| PfizerEliquis | $360 | $44,98745 claims |
| Boehringer IngelheimJardiance | $51 | $26,59415 claims |
| NovartisEntresto | $122 | $21,73716 claims |
| GSKTrelegy Ellipta | $476 | $19,29827 claims |
| AstraZenecaFarxiga | $409 | $12,79215 claims |
| MerckLagevrio (Eua) | $50 | $5,77316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,415 family providers in Alabama.
Other family in Gadsden
- Emma ArquitolaGadsden$13K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.